Early treatment and treat to target lead to early intensive therapy in many IBD patients. This is associated with cost, safety and quality of life issue. Treatment de-escalation is thus a logical option to discuss with the patients. The Crohn’s & Colitis Foundation and ECCO have teamed up to bring you key thought leaders from either side of the Atlantic to discuss de-escalation of therapy methodology.
Alan C. Moss, MDPeer